Lars Marcher
Executive Chairman @ Vascular Technology
Copenhagen, Denmark
Lars Marcher is a Series A investor at Vascular Technology in Copenhagen focused on Consulting and Health Care. Lars Marcher is the Executive Chairman of Vascular Technology. Lars Marcher attended the Macquarie University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Lars Marcher invests in
Stages Lars Marcher invests in
Countries Lars Marcher invests in
Investment Focus
Industry
- Consulting 1 (100%)
- Health Care 1 (100%)
- Medical Device 1 (100%)
- Product Design 1 (100%)
- Clinical Trials 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dawn Health
|
Dawn Health is a digital health company offering life-changing digital health therapies driving improved patient outcomes beyond the pill. The company is enabling to design, develop, and service medical device software. They help people live better and longer lives through technology and aim to accelerate digital health globally through strategicconsulting and the development of innovative digital health products together with their partners. As MedTech specialists, they create life-changing solutions with a strategic focus on digital health, SaMD, GxP software, and IoT within healthcare. Dawn Health envisions a time where digital health solutions will revolutionize how people worldwide achieve higher standards of health, and access services to promote and protect their health and well-being. The company has a global ambition to be the preferred Digital Health Partner to the life science industry, and through their partnerships and ventures, to impact one million lives by 2030 through digital interventions. | $25M / Series A / Dec 01, 2021 |
Co-Investors
About Vascular Technology
Vascular Technology manufactures, develops, and markets surgical devices, intraoperative doppler, monitors, and suction irrigation systems.
Vascular Technology Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Greg Groenke
CEO
|
|||
|
Lars Marcher
Executive Chairman
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lars Marcher invest in?
Lars Marcher invests primarily in Consulting, Health Care and Medical Device startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lars Marcher last invest?
The most recent investment recorded for Lars Marcher closed in Dec 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
